Focus: Simbex is a biomechanical device company focused on musculoskeletal injury treatment and rehabilitation, operating as a specialized biotech in the medical device space. The company is headquartered in Lebanon, NH with minimal public financial visibility.
Profile data last refreshed 1h ago · AI intelligence enriched 2mo ago
Simbex is a speculative, early-stage medical device play with high execution risk; join only if you have device-sector expertise and appetite for pre-revenue stage volatility.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Simbex
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Simbex's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications